Large-scale DNA organization is a prognostic marker of breast cancer survival.

about

Large-scale DNA organization is a prognostic marker of breast cancer survival.

Item

http://www.wikidata.org/entity/Q47585688

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Large-scale DNA organization is a prognostic marker of breast cancer survival.

@en

Large-scale DNA organization is a prognostic marker of breast cancer survival.

@nl

type

Item

label

Large-scale DNA organization is a prognostic marker of breast cancer survival.

@en

Large-scale DNA organization is a prognostic marker of breast cancer survival.

@nl

prefLabel

Large-scale DNA organization is a prognostic marker of breast cancer survival.

@en

Large-scale DNA organization is a prognostic marker of breast cancer survival.

@nl

P1476

Large-scale DNA organization is a prognostic marker of breast cancer survival.

@en

P2093

Alan Harrison

http://www.w3.org/2001/XMLSchema#string

Alan Nichol

http://www.w3.org/2001/XMLSchema#string

Anita Carraro

http://www.w3.org/2001/XMLSchema#string

Malcolm Hayes

http://www.w3.org/2001/XMLSchema#string

Mira Keyes

http://www.w3.org/2001/XMLSchema#string

Qian Ye

http://www.w3.org/2001/XMLSchema#string

Sam Leung

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Imaging biomarker roadmap for cancer studies

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.

A Java application for tissue section image analysis.

Nuclear cytometric changes in breast carcinogenesis.

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

P2888

s12032-017-1068-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-017-1068-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martial Guillaud

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29214466

http://www.w3.org/2001/XMLSchema#string